BCL11B anticorps (N-Term)
Aperçu rapide pour BCL11B anticorps (N-Term) (ABIN347801)
Antigène
Voir toutes BCL11B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Reacts with human 95 kDa protein
-
Réactivité croisée
- Souris
-
Réactivité croisée (Details)
- Cross reacts with human BCL11A (91 kDa). May cross react with BCL11B & A from mouse and other species, due to the homology.
-
Purification
- Antiserum
-
Immunogène
- Synthetic peptide derived from Nter domain of common domain of human BCL-11B and BCL-11A
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 1/50 to 1/500 - WB : 1/200 to 1/2 000 -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Must be reconstituted in distilled water.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Date de péremption
- 24 months
-
-
- BCL11B (B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B))
-
Autre désignation
- B-Cell Lymphoma/leukemia 11B (BCL-11B)
-
Sujet
- Tumor-suppressor protein involved in T-cell lymphomas. May function on the P53-signaling pathway. May be a key regulator of both differentiation and survival during thymocyte development. Repress transcription through direct, TFCOUP2-independent binding to a GC-rich response element
-
UniProt
- Q9C0K0
Antigène
-